SNIFF II: Defining the Normal Range for Maximal Sniff Diaphragm Thickening Fraction
Study Details
Study Description
Brief Summary
This study is investigating the normal range of maximal diaphragm thickness during a sniff inspiratory manoeuvre using ultrasound in healthy subjects stratified by age and gender.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Diaphragm dysfunction is associated with poor clinical outcomes in critically ill patients but is difficult to diagnose. Traditionally, diaphragm function is measured by evaluating inspiratory muscle strength via maximal inspiratory pressure (MIP). However, this technique relies on a volitional maximal effort and can be challenging for patients to perform.
An alternative to measuring inspiratory muscle strength is the sniff inspiratory pressure approach. During short, sharp sniffs, the diaphragm is maximally activated.
Currently, there are no reported values of the normal range of maximal diaphragm thickness during a sniff maneuver. This study will define the normal range of values for sniff maximal diaphragm thickening fraction, maximal thickening against an occluded airway, and diaphragm thickening during resting tidal breathing in healthy subjects.
Study Design
Outcome Measures
Primary Outcome Measures
- Sniff diaphragm thickening fraction [Day 1]
Thickening of the diaphragm during an inspiratory sniff
- Maximal diaphragm thickening fraction [Day 1]
Thickening of the diaphragm during a maximal inspiratory effort
- Resting tidal thickening fraction [Day 1]
Thickening of the diaphragm during resting tidal breathing
Eligibility Criteria
Criteria
Inclusion Criteria:
- Over 18 years of age
Exclusion Criteria:
- Antecedent history of neuromuscular or cardiorespiratory disease
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University Health Network | Toronto | Ontario | Canada | M5G 2N2 |
Sponsors and Collaborators
- University Health Network, Toronto
Investigators
- Principal Investigator: Ewan C Goligher, MD, PhD, University Health Network, Toronto
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 15-8998-AE